Arjun Pandian¹, Raju Ramasubbu², Kaliyaperumal Ashokkumar³ and Ruchi Badoni Semwal^4
1Division of Research and Innovation, Department of Biotechnology, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai, Tamil Nadu, India
²Department of Biology, The Gandhigram Rural Institute (Deemed to be University), Gandhigram, Dindugal, Tamil Nadu, India
³School of Agriculture and Animal Sciences, The Gandhigram Rural Institute (Deemed to be University), Gandhigram, Dindigul, Tamil Nadu, India
⁴VSKC Government Postgraduate College, Dakpathar, Dehradun, Uttarakhand, India

Part of the book: The Essential Guide to Alkaloids

Abstract

Vinblastine, vincristine, vinleurosine, vindoline, and catharanthine are notable monoterpenoid indole alkaloids consequential from the plant periwinkle. Vinblastine, vincristine, vinleurosine, and catharanthine are anticancer compounds. Catharanthus roseus belongs to the family of Apocynaceae and has pink and white flowered, used numerous illnesses, including diabetes, cancer, high blood pressure (HBP), constipation, asthma, menorrhagia, rheumatism, indigestion, skin conditions, bloody diarrhoea, and sadness are treated with it. Catharanthine is approximately completely accumulated in the wax exudates on the plant leaf surface, while vindoline is fashioned in specialized leaf cells internally. The plant has numerous pharmacological effects, including antioxidant, antimicrobial, antifeedant, anti-sterility, anthelmintic, antidiabetic and antidiarrheal. Due to independent enlargement in liquid medium exclusive of the use of exogenous hormones, established biochemical and genetic expression, and the potential for terpenoid indole alkaloids such as serpentine, ajmalicine, phenylalanine, tyrosine, tabersonine, catharanthine, and lochnericine to be elicited by methyl jasmonate, chitosan, and fungal elicitation, hairy root culture may perhaps entirely scale up to an industrial scale.

Keywords: antidiabetic, ajmalicine, cancer, lochnericine, vinblastine, vincristine

References

Almagro L, Gutierrez J, Pedreño MA, Sottomayor M. 2014. Synergistic and additive
influence of cyclodextrins and methyl jasmonate on the expression of the terpenoid
indole alkaloid pathway genes and metabolites in Catharanthus roseus cell cultures.
Plant Cell Tissue Organ Cult., 119, 543–551.
Almagro L, Sabater-Jara AB, Belchi-Navarro S, Fernandez-Perez F, Bru R, Pedreño MA.
2011. Effect of UV light on secondary metabolite biosynthesis in plant cell cultures
elicited with cyclodextrins and methyljasmonate. In Plants and Environment, 1st ed.;
Vasanthaiah, H. K. N., Kambiranda, D., Eds.; InTech Janeza Trdine: Rijeka, Croatia,
1, 115–136.
Aslam J, Khan SH, Siddiqui ZH, Fatima Z, Maqsood M, Bhat MA, Nasim SA, Ilah A,
Ahmad IZ, Khan SA, Mujib A. 2010. Catharanthus roseus (L.) G. Don. An important
drug: it’s applications and production, Pharm. Glob., 4(12), 1-6.
Aslam J, Mujib A, Nasim SA, Sharma MP. 2002. Screening of vincristine yield in ex vitro
and in vitro somatic embryos derived plantlets of Catharanthus roseus L. (G) Don.
Sci. Hortic., 119, 325-329.
Bagnyukova TV, Serebriiskii IG, Zhou Y, Hopper-Borge EA, Golemis EA, Astsaturov I.
2010. Chemotherapy and signaling: how can targeted therapies supercharge cytotoxic
agents? Cancer Biol. Ther., 10, 839-853.
Barthe L, Ribet JP, Pelissou M, 2002. Optimization of the separation of Vinca alkaloids by
nonaqueous capillary electrophoresis. J. Chromatogr. A, 968 (1-2), 241-250.
Boller T, Felix G. 2009. A renaissance of elicitors: perception of microbe‐associated
molecular patterns and danger signals by pattern recognition receptors. Annu. Rev.
Plant Biol., 60, 379-406.
Carqueijeiro I, Noronha H, Duarte P, Geros H, Sottomayor M. 2013. Vacuolar transport of
the medicinal alkaloids from Catharanthus roseus is mediated by a proton-driven
antiport. Plant Physiol., 162, 1486–1496.
Das S, Sharangi AB. 2017. Madagascar periwinkle (Catharanthus roseus L.): Diverse
medicinal and therapeutic benefits to humankind. J. Pharmacogn. Phytochem., 6(5),
1695–701.
Deus-Neumann B, Stöckigt J, Zenk MH. 1987. Radioimmunoassay for the quantitative
determination of catharanthine. Planta Med., 53(2), 184-188.
Goldhaber-Pasillas GD, Mustafa NR, Verpoorte R. 2014. Jasmonic Acid Effect on the Fatty
Acid and Terpenoid Indole Alkaloid Accumulation in Cell Suspension Cultures of
Catharanthus roseus. Molecules, 19, 10242–10260.
Gupta MM, Singh DV, Tripathi AK, Pandey R, Verma RK, Singh S, Shasany AK, Khanuja
SPS. 2005. Simultaneous Determination of Vincristine, Vinblastine, Catharanthine,
and Vindoline in Leaves of Catharanthus roseus by High-Performance Liquid
Chromatography. J. Chromatogr. Sci., 43(9), 450-453.
Hallard D, van der Heijden R, Verpoorte R, Lopez-Cardoso I, Pasquali G, Memelink J,
Hoge JHC. 1997. Suspension cultured transgenic cells of Nicotiana tabacum
expressing tryptophan decarboxylase and strictosidine synthase cDNAs from
Catharanthus roseus produce strictosidine upon feeding of secologanin. Plant Cell
Rep., 17, 50–54.
Horvath P, Ivanyi G. 1982. Quantitative analysis of natural drugs III. Densitometric
determination of vinblastine and other alkaloids of Catharantus roseus. Acta Pharm.
Hung., 52(4), 150-157.
Jackson DV, Castle MC, Bender RA. 1978. Biliary excretion of vincristine. Clin.
Pharmacol. Ther. 24, 101–107.
Jaggi M, Kumar S, Sinha AK. 2011. Overexpression of an apoplastic peroxidase gene
CrPrx in transgenic hairy root lines of Catharanthus roseus. Appl. Microbiol.
Biotechnol., 90, 1005–1016.
Kabesh K, Senthilkumar P, Ragunathan R, Kumar RR. 2015. Phyto-chemical analysis of
Catharanthus roseus plant extract and its antimicrobial activity. Int. J. Pure App.
Biosci., 3(2), 162-72.
Kuboyama, T., Yokoshima, S., Tokuyama, H. and Fukuyama, T. 2004. Stereocontrolled
total synthesis of (+)- Vinblastine. Pure Appl. Chem., 75, 29-38.
Kumar A. 2016. Vincristine and vinblastine: a review. Int. J. Med. Pharm. Sci., 6(1), 23-30.
Li M, Peebles CA, Shanks JV, San KY. 2011. Effect of sodium nitroprusside on growth
and terpenoid indole alkaloid production in Catharanthus roseus hairy root cultures.
Biotechnol. Prog., 27, 625–630.
Lin Z, Qing-Hui G, Yuan-Gang Z, Lei Y, Yu-Liang M, Yang L. 2014. Simultaneous
quantitative determination of five alkaloids in Catharanthus roseus by HPLC-ESI MS/MS. Chinese J. Nat. Med., 12(10), 786-793.
Madrid E, Corchete P. 2010. Silymarin secretion and its elicitation by methyl jasmonate in
cell cultures of Silybum marianum is mediated by phospholipase D-phosphatidic acid.
J. Exp. Bot., 61(3), 747-754.
Mu FS, Yang L, Wang W. 2012. Negative-pressure cavitation extraction of four main vinca
alkaloids from Catharanthus roseus leaves. Molecules, 17 (8), 8742-8752.
Naaranlahti T, Auriola S, Lapinjoki SP. 1991. Growth related dimerization of vindoline
and catharanthine in Catharanthus roseus and effect of wounding on the process.
Phytochemistry, 30, 1451–1453.
Noble RL. 1990. The discovery of the Vinca alkaloids – chemotherapeutic agents against
cancer. Biochem. Cell Biol., 68(12), 1344-1351.
Okouneva T, Hill BT, Wilson L, 2003. The effects of vinflunine, vinorelbine, and
vinblastine on centromere dynamics. Mol. Cancer Ther., 2(5), 427-436.
Owellen RJ, Hartke CA, Hains FO. 1977. Pharmacokinetics and metabolism of vinblastine
in humans. Cancer Res., 37, 2597–2602.
Owellen RJ, Hartke CA. 1975. The pharmacokinetics of 4-acetyl tritium vinblastine in two
patients. Cancer Res., 35, 975–980.
Peebles C, Sander GW, Hughes EH, Peacock R, Shanks JV, San KY. 2011. The expression
of 1-deoxy-D-xylulose synthase and geraniol-10-hydroxylase or anthranilate synthase
increases terpenoid indole alkaloid accumulation in Catharanthus roseus hairy roots.
Metab. Eng., 13, 234–240.
Pennanen S, Huhtikangas A. 1990. Photochemical one-pot synthesis of vinblastine and
vincristine. Photochem. Photobiol., 51(5), 515-518.
Raina SK, Wankhede DP, Jaggi M, Singh P, Jalmi SK, Raghuram B, Sheikh AH, Sinha
AK. 2012. CrMPK3, a mitogen activated protein kinase from Catharanthus roseus and
its possible role in stress induced biosynthesis of monoterpenoid indole alkaloids.
BMC Plant Biol., 12, 134.
Rosenthal S, Kaufman S. 1974. Vincristine neurotoxicity. Ann. Intern. Med., 80, 733–737.
Ruiz-May E, Galaz-Ávalos RM, Loyola-Vargas VM. 2009. Differential secretion and
accumulation of terpene indole alkaloids in hairy roots of Catharanthus roseus treated
with methyl jasmonate. Mol. Biotechnol., 41, 278–285.
Sahi N, Mostajeran A, Ghanadian M. 2022. Changing in the production of anticancer drugs
(vinblastine and vincristine) in Catharanthus roseus (L.) G. Don by potassium and
ascorbic acid treatments. Plant Soil Environ., 68, 18–28.
Sertel S, Fu YJ, Zu YG, 2011. Molecular docking and pharmacogenomics of Vinca
alkaloids and their monomeric precursors, vindoline and catharanthine. Biochem
Pharmacol, 81 (6): 723-735.
Sethi VS, Kimball JC. 1981. Pharmacokinetics of vincristine sulfate in children. Cancer
Chemother. Pharmacol. 6, 111–115.
Sottomayor M, Barceló AR. 2006. The Vinca alkaloids: From biosynthe-sis and
accumulation in plant cells, to uptake, activity and metabolism in animal cells. In:
Studies in Natural Products Chemistry. Elsevier, pp. 813–857.
Tam A, Gotoh H, Robertson WH, Boger DL. 2010. Catharanthine C16 substituent effects
on the biomimetic coupling with vindoline: Preparation and evaluation of a key series
of vinblastine analogues. Bioorg. Med. Chem. Lett., 20, 6408-6410.
Tikhomiroff C, Jolicoeur M. 2002. Screening of Catharanthus roseus secondary
metabolites by high-performance liquid chromatography. J. Chromatogr. A, 955(1),
87-93.
Van den Berg HW, Desai ZR, Wilson R, Kennedy G, Bridges JM, Shanks RG. 1982. The
pharmacokinetics of vincristine in man: reduced drug clearance associated with raised
serum alkaline phosphatase and dose-limited elimination. Cancer Chemother.
Pharmacol., 8, 215–219.
Van Der Heijden R, Jacobs DI, Snoeijer W, Hallard D, Verpoorte R. 2004. The
Catharanthus alkaloids: pharmacognosy and biotechnology. Curr. Med. Chem., 11(5),
607–628.
Yu F, de Luca V. 2013. ATP-binding cassette transporter controls leaf surface secretion of
anticancer drug components in Catharanthus roseus. Proc. Natl. Acad. Sci., 110,
15830–15835.
Zandi M. 2021. Cytotoxicity of taxol in combination with vincristine and vinblastine
against A375 cell line. Gene Cell Tissue, 8(4), e114359.
Zhao J, Hu Q, Guo YQ, Zhu WH. 2001. Effects of stress factors, bioregulators, and
synthetic precursors on indole alkaloid production in compact callus clusters cultures
of Catharanthus roseus. Appl. Microbiol. Biotechnol., 55, 693–698.
Zhao J, Zhu WH, Hu Q, He XW. 2001. Enhanced indole alkaloid production in suspension
compact callus clusters of Catharanthus roseus: Impacts of plant growth regulators
and sucrose. Plant Growth Reg., 33, 33–41.
Zhao J, Zhu WH, Hu Q. 2001. Enhanced catharanthine production in Catharanthus roseus
cell cultures by combined elicitor treatment in shake flasks and bioreactors. Enzym.
Microb. Technol., 28, 673–681.
Zhou XJ, Rahmani R. 1992. Preclinical and clinical pharmacology of Vinca alkaloids.
Drugs, 44(Suppl 4), 66-69.
Zhou XJ, Zhou-Pan XR, Gauthier T, Placidi M, Maurel P, Rahmani R. 1993. Human liver
microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation.
Metabolic drug interactions. Biochem. Pharmacol., 45, 853–861.
Zhou-Pan XR, Seree E, Zhou XJ. 1993. Involvement of human liver cytochrome P450 3A
in vinblastine metabolism: drug interactions. Cancer Res., 53, 5121–5126.